168 related articles for article (PubMed ID: 35846125)
1. BTC as a Novel Biomarker Contributing to EMT
Shen T; Yang T; Yao M; Zheng Z; He M; Shao M; Li J; Fang C
Front Genet; 2022; 13():875617. PubMed ID: 35846125
[No Abstract] [Full Text] [Related]
2. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
3. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
4. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
6. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
7. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of DOCK6 in oral squamous cell cancer promotes cellular migration and invasion and is associated with poor prognosis.
Zhang ZY; Sun YY; Wang HC; Fu WN; Sun CF
Arch Oral Biol; 2022 Jan; 133():105297. PubMed ID: 34742001
[TBL] [Abstract][Full Text] [Related]
9. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
10. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition.
Ding X; Wang X; Gong Y; Ruan H; Sun Y; Yu Y
Oncol Lett; 2017 Apr; 13(4):2281-2289. PubMed ID: 28454392
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
12. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.
Zhao Z; Chu W; Zheng Y; Wang C; Yang Y; Xu T; Yang X; Zhang W; Ding X; Li G; Zhang H; Zhou J; Ye J; Wu H; Song X; Wu Y
Cell Commun Signal; 2021 Dec; 19(1):121. PubMed ID: 34922580
[TBL] [Abstract][Full Text] [Related]
15. CircRNA HIPK3 promotes the progression of oral squamous cell carcinoma through upregulation of the NUPR1/PI3K/AKT pathway by sponging miR-637.
Jiang W; Zhang C; Zhang X; Sun L; Li J; Zuo J
Ann Transl Med; 2021 May; 9(10):860. PubMed ID: 34164494
[TBL] [Abstract][Full Text] [Related]
16. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
Li C; Lin XF; Wang JN; Ren XS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of XRN2 acts as an oncogene in oral squamous cell carcinoma and correlates with poor prognosis.
Liu JC; Gao L; Li SM; Zheng JJ; Li DG; Zhi KQ; Ren WH
Pathol Res Pract; 2021 Mar; 219():153355. PubMed ID: 33626405
[TBL] [Abstract][Full Text] [Related]
18. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
19. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
Fan QC; Tian H; Wang Y; Liu XB
Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
[TBL] [Abstract][Full Text] [Related]
20. ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Qu Y; He Y; Yang Y; Li S; An W; Li Z; Wang X; Han Z; Qin L
J Cancer; 2020; 11(9):2621-2631. PubMed ID: 32201532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
